Inhalation of aerosolised drugs is widely used in the treatment of asthma. The inhaler systems can be divided into three groups: (1) pressurised metered dose inhalers, (2) dry powder inhalers, and (3) nebulisers. The Turbohaler (Turbuhaler in some countries), a multidose dry powder inhaler, is a device from the second group. The clinical effect and deposition of budesonide is higher when using a Turbohaler than when using a pressurised metered dose inhaler. 12 However, a sufficient peak inspiratory flow through the inhaler (PIFTBH) is required to achieve a large percentage of small respirable particles of the drug and an optimal lung deposition.34 Due to the built-in resistance of the Turbohaler this could be a problem in asthmatic patients. Several studies have shown that a flow ranging from 28 to 36 1/min is sufficient to give good lung deposition and clinical efficacy.2 4-8 These studies, however, were all performed under supervision of a physician or technician. We have therefore investigated whether a sufficient PIFTBH is generated when patients use a Turbohaler unsupervised at home.
Methods
Thirty patients with asthma according to ATS criteria9 who attended our outpatient clinic were consecutively recruited into the study. The clinical characteristics of the patients are given in the table. All patients had used a budesonide Turbohaler for at least two months before the study and continued their maintenance dose of budesonide during the study. The study was approved by the local ethics committee of our hospital and all patients gave written informed consent. 
Discussion
The primary objective of this study was to examine the peak inspiratory flow generated by asthmatic patients during maintenance treatment at home with a Turbohaler (PIFTBH).
Results were unlikely to have been affected by training as all patients were current users of the Turbohaler for a relatively long time. However, the presence of the pneumotachograph could be regarded as a cause of improved flow rates. In our opinion this could lead to a more regular use of budesonide but probably not to an increase in the value of PIFTBH since verbal stimulation during the measurements at home was absent in contrast to studies performed under direct supervision. (February 1966; 51:117-18) . We agree that accurate hospital assessment and selection of the patient with COPD is essential before enrolment into a pulmonary rehabilitation programme, whether performed as an inpatient, outpatient, or mainly in the home. However, Dr Wijkstra also suggests that patients with exercise hypoxaemia should be excluded from home programmes, which will include patients with more advanced COPD.
patients. through the Turbohaler in asthmatic
Few studies have investigated the effects of pulmonary rehabilitation in patients with severe COPD. In a recent controlled study of rehabilitation reported by Goldstein and colleagues' patients with a forced expiratory volume in one second (FEVI) of less than 40% predicted were selected and showed improvements in exercise tolerance and quality of life after rehabilitation. Oxygen prescription during exercise was adjusted to maintain arterial oxygen saturation at 85-90% and rehabilitation continued at home after the initial inpatient programme. In a retrospective study patients with a mean FEV, of 20% predicted with severe hypercapnia (Paco2 >7.2 kPa) showed increases in exercise capacity after physical training.2
Patients with more severe COPD have a greater impairment of quality of life related to the severity of their hypoxaemia,3 and considerable anxiety and depression which further impairs activities of daily living. This patient group may be particularly suitable for home pulmonary rehabilitation programmes, although outcome measures may differ in view of the greater degree of disability present. Ambulatory oxygen devices are widely available to correct hypoxaemia during physical training and we have used these in the home without complications. More controlled studies are required to assess selection, effectiveness, safety, and costs of rehabilitation in patients with advanced COPD. The remainder of the book is dedicated to specific occupational lung diseases. Each chapter opens with an account of the history and a thorough review of the epidemiology before moving on to clinical and pathological aspects of the condition. The disease coverage is comprehensive rather than encyclopaedic, but this has the advantage of producing a book which is not too weighty, and which can equally be read in the library or used in the field.
For me, however, the real strength of this book is its ability to stimulate interest in, and then guide, research into occupational lung disease. This is an excellent text and is recommended. - 
